GSK Contracted to Produce World’s First Malaria Vaccine Top story

Comments 1256 Views Kampala, Uganda
Anopheles_gambiae_flex Online image


In short
The landmark award, valued at up to USD 170 million, will lead to 18 million doses of the RTS,S vaccine being available over the next three years, potentially saving thousands of young lives annually. The RTS,S malaria vaccine – the result of 35 years of research and development – is the first-ever vaccine against a parasitic disease.


IP: Referrer: . FirstClickFree: 0. Clicks by IP: ?. Clicks by cookie: ?.